Ruiz Martín, Anguita Manuel, Castillo Juan C, Delgado Mónica, Romo Elías, Torres Francisco, Mesa Dolores, Franco Manuel, Vallés Federico
Cardiology Service, Hospital Reina Sofía, Córdoba, Spain.
J Heart Valve Dis. 2006 Jan;15(1):122-4.
Removal of the entire infected system is the traditionally indicated management of pacemaker lead endocarditis (PLE), based on expert recommendations. Herein is described the present authors' experience with this condition.
Between 1987 and 2004, all consecutive patients with PLE treated at a tertiary referral university hospital and a community hospital were prospectively selected. Clinical features, management and outcome were analyzed.
Thirteen cases of PLE were diagnosed. Surgery was performed in 10 cases, and medical treatment alone in three (due to advanced age in two cases and because of terminal colon cancer in one case). Four subjects died before discharge: three deaths occurred after surgery (one patient died due to refractory ventricular arrhythmia and two from persistent sepsis), and one unoperated patient died from sepsis and severe renal failure. No deaths or late surgeries were observed after a mean follow up period of 37 +/- 14 months. Both patients who survived hospitalization and underwent only medical treatment were free from late complications after 30 and 60 months follow up, respectively.
Some patients with PLE present a good evolution without surgery, suggesting that surgical treatment is not mandatory in this situation. However, an indication for surgery may be similar to that for other cases of infective endocarditis.
根据专家建议,传统上对于起搏器导线心内膜炎(PLE)的治疗是移除整个感染系统。本文介绍了作者对这种疾病的治疗经验。
前瞻性选取了1987年至2004年间在一家三级转诊大学医院和一家社区医院接受治疗的所有连续性PLE患者。分析其临床特征、治疗方法及预后。
共诊断出13例PLE。10例行手术治疗,3例仅接受药物治疗(2例因年龄较大,1例因晚期结肠癌)。4例患者在出院前死亡:3例术后死亡(1例因难治性室性心律失常死亡,2例因持续性败血症死亡),1例未手术患者死于败血症和严重肾衰竭。平均随访37±14个月后,未观察到死亡或晚期手术情况。住院存活且仅接受药物治疗的2例患者,分别在随访30个月和60个月后无晚期并发症。
部分PLE患者未经手术也有良好转归,提示在此情况下手术治疗并非必需。然而,手术指征可能与其他感染性心内膜炎病例相似。